Activest Wealth Management’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8K Hold
166
﹤0.01% 488
2026
Q1
$8.14K Hold
166
﹤0.01% 726
2025
Q4
$5.03K Hold
166
﹤0.01% 766
2025
Q3
$3.19K Hold
166
﹤0.01% 718
2025
Q2
$1.86K Hold
166
﹤0.01% 696
2025
Q1
$1.7K Hold
166
﹤0.01% 686
2024
Q4
$3.22K Hold
166
﹤0.01% 402
2024
Q3
$4.07K Sell
166
-1
-0.6% -$35 ﹤0.01% 379
2024
Q2
$7.66K Buy
+167
New +$6.66K ﹤0.01% 316

Other funds holding ORKA

Activest Wealth Management's ORKA Position: Q2 2026 in Review

Activest Wealth Management held its Oruka Therapeutics (ORKA) position steady in Q2 2026 at 166 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Activest Wealth Management first reported a position in ORKA in Q2 2024 and has held it in 9 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Activest Wealth Management held 166 shares of Oruka Therapeutics worth $15.8K as of Q2 2026.
  • Activest Wealth Management left its Oruka Therapeutics share count unchanged in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #488 holding.
  • Activest Wealth Management first reported a position in Oruka Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.